Cargando…
Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo
BACKGROUND AND METHODS: Applications of the anticancer agent, ellipticine, have been limited by its hydrophobicity and toxicity. An efficient delivery system is required to exploit the enormous potential of this compound. Recently, EAK16-II, an ionic-complementary, self-assembling peptide, has been...
Autores principales: | Wu, Yan, Sadatmousavi, Parisa, Wang, Rong, Lu, Sheng, Yuan, Yong-fang, Chen, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396387/ https://www.ncbi.nlm.nih.gov/pubmed/22802684 http://dx.doi.org/10.2147/IJN.S31858 |
Ejemplares similares
-
Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine
por: Ma, Weina, et al.
Publicado: (2012) -
Sequence Effect of Self-Assembling Peptides on the Complexation and In Vitro Delivery of the Hydrophobic Anticancer Drug Ellipticine
por: Fung, Shan Yu, et al.
Publicado: (2008) -
Self/Co-Assembling Peptide, EAR8-II, as a Potential Carrier for a Hydrophobic Anticancer Drug Pirarubicin (THP)—Characterization and in-Vitro Delivery
por: Sadatmousavi, Parisa, et al.
Publicado: (2013) -
The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells
por: Poljaková, Jitka, et al.
Publicado: (2008) -
Anticancer and Immunomodulatory Activities of a Novel Water-Soluble Derivative of Ellipticine
por: Costa de Oliveira, Regiane, et al.
Publicado: (2020)